Your browser doesn't support javascript.
loading
IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis.
Fuss, Ivan J; Joshi, Bharat; Yang, Zhiqiong; Degheidy, Heba; Fichtner-Feigl, Stefan; de Souza, Heitor; Rieder, Florian; Scaldaferri, Franco; Schirbel, Anja; Scarpa, Melania; West, Gail; Yi, Chuli; Xu, Lili; Leland, Pamela; Yao, Michael; Mannon, Peter; Puri, Raj K; Fiocchi, Claudio; Strober, Warren.
Afiliación
  • Fuss IJ; Mucosal Immunity Section, Laboratory of Host Defenses, NIAID NIH, Bethesda, Maryland, USA.
  • Joshi B; Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research FDA, Bethesda, Maryland, USA.
  • Yang Z; Mucosal Immunity Section, Laboratory of Host Defenses, NIAID NIH, Bethesda, Maryland, USA.
  • Degheidy H; Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research FDA, Bethesda, Maryland, USA.
  • Fichtner-Feigl S; Department of Surgery, University of Regensburg, Regensburg, Germany.
  • de Souza H; Department of Pathobiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Rieder F; Department of Pathobiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Scaldaferri F; Department of Pathobiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Schirbel A; Department of Pathobiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Scarpa M; Department of Pathobiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • West G; Department of Pathobiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Yi C; Mucosal Immunity Section, Laboratory of Host Defenses, NIAID NIH, Bethesda, Maryland, USA.
  • Xu L; Mucosal Immunity Section, Laboratory of Host Defenses, NIAID NIH, Bethesda, Maryland, USA.
  • Leland P; Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research FDA, Bethesda, Maryland, USA.
  • Yao M; Mucosal Immunity Section, Laboratory of Host Defenses, NIAID NIH, Bethesda, Maryland, USA.
  • Mannon P; Mucosal Immunity Section, Laboratory of Host Defenses, NIAID NIH, Bethesda, Maryland, USA.
  • Puri RK; Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research FDA, Bethesda, Maryland, USA.
  • Fiocchi C; Department of Pathobiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Strober W; Mucosal Immunity Section, Laboratory of Host Defenses, NIAID NIH, Bethesda, Maryland, USA.
Gut ; 63(11): 1728-36, 2014 Nov.
Article en En | MEDLINE | ID: mdl-24515806
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoantígenos / Colitis Ulcerosa / Subgrupos Linfocitarios / Subunidad alfa2 del Receptor de Interleucina-13 / Células T Asesinas Naturales / Mucosa Intestinal Límite: Humans Idioma: En Revista: Gut Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoantígenos / Colitis Ulcerosa / Subgrupos Linfocitarios / Subunidad alfa2 del Receptor de Interleucina-13 / Células T Asesinas Naturales / Mucosa Intestinal Límite: Humans Idioma: En Revista: Gut Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido